This article is for educational purposes only. Thymosin Alpha-1 (sold as Zadaxin in clinical settings) is a prescription medication in most countries and a research peptide in others. Always consult a physician before use, especially if immunocompromised or on immunosuppressive therapy.
Thymosin Alpha-1 (TĪ±1) is a 28-amino-acid peptide naturally secreted by the thymus gland ā the central immune organ responsible for T-cell maturation and immune education. It was first isolated in 1977 by Dr. Allan Goldstein at George Washington University from thymic tissue and has since been the subject of over 4,000 published studies, making it one of the most rigorously researched peptides in existence.
The thymus begins to involute (shrink and lose function) after puberty, with significant thymic atrophy occurring by age 40ā50. This thymic decline is considered one of the primary drivers of immunosenescence ā the progressive deterioration of immune function with age that increases susceptibility to infection, cancer, and autoimmune disease.
TĪ±1 essentially provides the immune signaling that a declining thymus can no longer produce ā restoring T-cell maturation, improving immune surveillance, and recalibrating the inflammatory tone of the immune system toward optimal function.
Commercially, TĪ±1 is sold as Zadaxin (SciClone Pharmaceuticals) and is approved in more than 35 countries. It has been used clinically for decades for viral hepatitis, cancer immunotherapy adjuvant use, HIV-related immune dysfunction, and ā most recently ā COVID-19-related immune dysregulation.
TĪ±1 is an immunomodulator ā it normalizes immune function in both directions:
| Parameter | Detail |
|---|---|
| Dose | 1.6 mg SubQ per injection |
| Frequency | 2x per week (e.g. Monday/Thursday) |
| Duration | 4ā6 weeks |
| Cycles/year | 1ā2 cycles per year (autumn and spring recommended to optimize seasonal immune readiness) |
| Injection site | SubQ abdomen, thigh, or upper arm ā rotate |
| Parameter | Detail |
|---|---|
| Dose | 1.6 mg SubQ per injection |
| Frequency | 3x per week for first 4 weeks; then 2x per week for 4ā8 more weeks |
| Duration | 8ā12 weeks total |
| Monitoring | CD4/CD8 ratio, NK cell activity, inflammatory markers (CRP, IL-6) at baseline and week 8 |
| Stack | Add LL-37 (antimicrobial) and BPC-157 (gut/inflammation) for comprehensive chronic infection protocol |
| Parameter | Detail |
|---|---|
| Timing | 1.6mg SubQ on Day -7, Day -3, Day 0 (day of vaccination), and Day +7 |
| Evidence | RCTs show 2ā3x greater antibody titers in elderly subjects vs vaccination alone |
| Best for | Adults over 55 and immunocompromised individuals receiving influenza, pneumococcal, shingles, or hepatitis vaccines |
Thymosin Alpha-1 (whether sourced as Zadaxin or compounded) arrives as lyophilized powder in 1.6mg vials, typically pre-loaded with diluent (sterile water for injection). Standard reconstitution:
Zadaxin is the pharmaceutical-grade, clinically validated form of TĪ±1 ā used in all major clinical trials. It is more expensive but has unambiguous quality. Compounded TĪ±1 from licensed 503B compounding pharmacies is significantly cheaper and widely used by practitioners in longevity medicine ā with COA verification required. Both are appropriate with appropriate sourcing diligence.
| Compound | Dose | Synergy |
|---|---|---|
| Thymosin Alpha-1 | 1.6mg SubQ 2ā3x/week | Anchor ā T-cell and NK cell restoration |
| LL-37 | 100ā200mcg SubQ daily | Antimicrobial peptide; directly targets pathogens TA1's immune cells are responding to |
| BPC-157 | 250ā500mcg SubQ daily | Reduces gut-derived immune burden; anti-inflammatory complement |
| Vitamin D3 | 5,000ā10,000 IU/day | Critical VDR-mediated immune modulation; deficiency severely impairs immune function |
| Zinc Bisglycinate | 25ā30mg/day | Essential for T-cell development and function; zinc deficiency = immune collapse |
| Glutathione (liposomal) | 500mg/day | Master antioxidant; immune cell GSH depletion is a hallmark of immune senescence |
| Probiotics (multi-strain) | 50B CFU/day | 60ā70% of immune system resides in gut-associated lymphoid tissue; microbiome directly affects TA1 efficacy |
Thymosin Alpha-1 is one of the most versatile tools in a functional or integrative medicine practice. Key clinical considerations:
Thymosin Alpha-1 has one of the most robust safety profiles of any peptide in clinical use, backed by decades of pharmacovigilance data from Zadaxin:
Despite similar names, they are completely different peptides with non-overlapping mechanisms. Thymosin Alpha-1 is a thymic peptide that specifically modulates the immune system ā T-cells, NK cells, antigen presentation, and cytokine balance. TB-500 (synthetic Thymosin Beta-4) is a ubiquitous intracellular actin-binding peptide that drives tissue repair, cellular migration, and systemic healing. They can be combined ā and often are in comprehensive longevity protocols ā with no overlap or interaction.
In acute infection or post-viral applications, users typically report improved energy, reduced fatigue, and subjective immune improvement within 2ā3 weeks. In chronic infection and immune senescence contexts, 4ā6 weeks of consistent use is required for measurable changes in immune markers (CD4/CD8 ratio, NK activity, inflammatory cytokines).
Long-term continuous use has been studied in clinical contexts (hepatitis treatment) and appears safe. For healthy longevity optimization, 1ā2 cycles per year (4ā6 weeks each) is the standard recommendation ā sufficient to offset immunosenescence without the theoretical concern of chronic immune stimulation.
Yes ā TĪ±1 is fully profiled in the Emerald Wellness compound database with dosing protocols, interaction checking, and clinical reference data. It's a core component of the Immune Optimization protocol and the Pro Practitioner Suite's chronic infection management templates.
Log your TA-1 cycles, track CD4/CD8 ratio and inflammatory markers, and build the complete immune optimization stack with the Health Intelligence Advisor. Pro Practitioner Suite includes patient-level protocol management and SOAP note documentation.
Join the Waitlist ā